NDC 71335-2512 – Desvenlafaxine

Desvenlafaxine Succinate 100 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC71335-2512

Product details

Brand name
Desvenlafaxine
Generic name
Desvenlafaxine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204028
Marketed since
January 31, 2022
Listing expires
December 31, 2027
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Desvenlafaxine →

Package NDC codes (4)

Package NDCDescriptionSince
71335-2512-130 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2512-1)Jun 4, 2025
71335-2512-228 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2512-2)Jun 4, 2025
71335-2512-390 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2512-3)Jun 4, 2025
71335-2512-460 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2512-4)Jun 4, 2025

Other Desvenlafaxine products